We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Tilray is well placed to profit from expanding global cannabis legalization. Investors must assess their risk tolerance due to Tilray's high stock volatility. Research Tilray's financial health ...
Javier Hasse This Week In Cannabis: DeSantis' Anti-Weed Push, NY's Drug Decriminalization, Aurora's Record Earnings, Tilray And More Global News Cannabis news: DeSantis fights Florida's 2026 ...
Canopy Growth, which reported its fiscal Q3 recently, has performed the worst by far, and Village Farms and Organigram are down but by less than Tilray Brands. Tilray has dropped almost 3 times as ...
Tilray Brands (NasdaqGS:TLRY) Sees 19% Decline As Settlement In Lawsuit Weighs On Investor Sentiment
Tilray Brands experienced a challenging week, with a notable share price decline of 19%, possibly influenced by the broader market sell-off amid new U.S. tariffs. Despite Tilray's efforts to ...
NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and a global leader in medical cannabis ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback